| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ACCELERON PHARMA | 1,887,319 | 59,715,000 | 62.12% | ||
| 2 | PULMATRIX INC | 1,591,862 | 15,282,000 | 15.90% | ||
| 3 | ALIMERA SCIENCES INC | 3,148,355 | 14,514,000 | 15.10% | ||
| 4 | CERULEAN PHARMA INC | 1,437,441 | 6,612,000 | 6.88% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000950123-15-008469, filed 2015.08.11).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
